Global Molecular Diagnostics Systems Market Research Report 2023

Publication ID:

PB511243165

Publication Date:

November 13, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Molecular Diagnostics Systems market is projected to reach US$ 14890 million in 2029, increasing from US$ 10890 million in 2022, with the CAGR of 4.5% during the period of 2023 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Molecular Diagnostics Systems market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Abbott Laboratories
Qiagen N.V.
Roche Diagnostics
Hologic, Inc.
Grifols
Siemens Healthcare
Becton, Dickinson and Company
Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation)
Biom茅rieux Sa
Cepheid Inc
Segment by Type
PCR
Hybridization
DNA Sequencing
Segment by Application
Hospitals
Laboratories
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Molecular Diagnostics Systems report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers鈥� Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers鈥� Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Molecular Diagnostics Systems Market Overview
1.1 Product Overview and Scope of Molecular Diagnostics Systems
1.2 Molecular Diagnostics Systems Segment by Type
1.2.1 Global Molecular Diagnostics Systems Market Value Comparison by Type (2023-2029)
1.2.2 PCR
1.2.3 Hybridization
1.2.4 DNA Sequencing
1.3 Molecular Diagnostics Systems Segment by Application
1.3.1 Global Molecular Diagnostics Systems Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Laboratories
1.4 Global Molecular Diagnostics Systems Market Size Estimates and Forecasts
1.4.1 Global Molecular Diagnostics Systems Revenue 2018-2029
1.4.2 Global Molecular Diagnostics Systems Sales 2018-2029
1.4.3 Global Molecular Diagnostics Systems Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Molecular Diagnostics Systems Market Competition by Manufacturers
2.1 Global Molecular Diagnostics Systems Sales Market Share by Manufacturers (2018-2023)
2.2 Global Molecular Diagnostics Systems Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Molecular Diagnostics Systems Average Price by Manufacturers (2018-2023)
2.4 Global Molecular Diagnostics Systems Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Molecular Diagnostics Systems, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Molecular Diagnostics Systems, Product Type & Application
2.7 Molecular Diagnostics Systems Market Competitive Situation and Trends
2.7.1 Molecular Diagnostics Systems Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Molecular Diagnostics Systems Players Market Share by Revenue
2.7.3 Global Molecular Diagnostics Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Molecular Diagnostics Systems Retrospective Market Scenario by Region
3.1 Global Molecular Diagnostics Systems Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Molecular Diagnostics Systems Global Molecular Diagnostics Systems Sales by Region: 2018-2029
3.2.1 Global Molecular Diagnostics Systems Sales by Region: 2018-2023
3.2.2 Global Molecular Diagnostics Systems Sales by Region: 2024-2029
3.3 Global Molecular Diagnostics Systems Global Molecular Diagnostics Systems Revenue by Region: 2018-2029
3.3.1 Global Molecular Diagnostics Systems Revenue by Region: 2018-2023
3.3.2 Global Molecular Diagnostics Systems Revenue by Region: 2024-2029
3.4 North America Molecular Diagnostics Systems Market Facts & Figures by Country
3.4.1 North America Molecular Diagnostics Systems Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Molecular Diagnostics Systems Sales by Country (2018-2029)
3.4.3 North America Molecular Diagnostics Systems Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Molecular Diagnostics Systems Market Facts & Figures by Country
3.5.1 Europe Molecular Diagnostics Systems Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Molecular Diagnostics Systems Sales by Country (2018-2029)
3.5.3 Europe Molecular Diagnostics Systems Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Molecular Diagnostics Systems Market Facts & Figures by Country
3.6.1 Asia Pacific Molecular Diagnostics Systems Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Molecular Diagnostics Systems Sales by Country (2018-2029)
3.6.3 Asia Pacific Molecular Diagnostics Systems Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Molecular Diagnostics Systems Market Facts & Figures by Country
3.7.1 Latin America Molecular Diagnostics Systems Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Molecular Diagnostics Systems Sales by Country (2018-2029)
3.7.3 Latin America Molecular Diagnostics Systems Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Molecular Diagnostics Systems Market Facts & Figures by Country
3.8.1 Middle East and Africa Molecular Diagnostics Systems Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Molecular Diagnostics Systems Sales by Country (2018-2029)
3.8.3 Middle East and Africa Molecular Diagnostics Systems Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Molecular Diagnostics Systems Sales by Type (2018-2029)
4.1.1 Global Molecular Diagnostics Systems Sales by Type (2018-2023)
4.1.2 Global Molecular Diagnostics Systems Sales by Type (2024-2029)
4.1.3 Global Molecular Diagnostics Systems Sales Market Share by Type (2018-2029)
4.2 Global Molecular Diagnostics Systems Revenue by Type (2018-2029)
4.2.1 Global Molecular Diagnostics Systems Revenue by Type (2018-2023)
4.2.2 Global Molecular Diagnostics Systems Revenue by Type (2024-2029)
4.2.3 Global Molecular Diagnostics Systems Revenue Market Share by Type (2018-2029)
4.3 Global Molecular Diagnostics Systems Price by Type (2018-2029)
5 Segment by Application
5.1 Global Molecular Diagnostics Systems Sales by Application (2018-2029)
5.1.1 Global Molecular Diagnostics Systems Sales by Application (2018-2023)
5.1.2 Global Molecular Diagnostics Systems Sales by Application (2024-2029)
5.1.3 Global Molecular Diagnostics Systems Sales Market Share by Application (2018-2029)
5.2 Global Molecular Diagnostics Systems Revenue by Application (2018-2029)
5.2.1 Global Molecular Diagnostics Systems Revenue by Application (2018-2023)
5.2.2 Global Molecular Diagnostics Systems Revenue by Application (2024-2029)
5.2.3 Global Molecular Diagnostics Systems Revenue Market Share by Application (2018-2029)
5.3 Global Molecular Diagnostics Systems Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Corporation Information
6.1.2 Abbott Laboratories Description and Business Overview
6.1.3 Abbott Laboratories Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Abbott Laboratories Molecular Diagnostics Systems Product Portfolio
6.1.5 Abbott Laboratories Recent Developments/Updates
6.2 Qiagen N.V.
6.2.1 Qiagen N.V. Corporation Information
6.2.2 Qiagen N.V. Description and Business Overview
6.2.3 Qiagen N.V. Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Qiagen N.V. Molecular Diagnostics Systems Product Portfolio
6.2.5 Qiagen N.V. Recent Developments/Updates
6.3 Roche Diagnostics
6.3.1 Roche Diagnostics Corporation Information
6.3.2 Roche Diagnostics Description and Business Overview
6.3.3 Roche Diagnostics Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Roche Diagnostics Molecular Diagnostics Systems Product Portfolio
6.3.5 Roche Diagnostics Recent Developments/Updates
6.4 Hologic, Inc.
6.4.1 Hologic, Inc. Corporation Information
6.4.2 Hologic, Inc. Description and Business Overview
6.4.3 Hologic, Inc. Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Hologic, Inc. Molecular Diagnostics Systems Product Portfolio
6.4.5 Hologic, Inc. Recent Developments/Updates
6.5 Grifols
6.5.1 Grifols Corporation Information
6.5.2 Grifols Description and Business Overview
6.5.3 Grifols Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Grifols Molecular Diagnostics Systems Product Portfolio
6.5.5 Grifols Recent Developments/Updates
6.6 Siemens Healthcare
6.6.1 Siemens Healthcare Corporation Information
6.6.2 Siemens Healthcare Description and Business Overview
6.6.3 Siemens Healthcare Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Siemens Healthcare Molecular Diagnostics Systems Product Portfolio
6.6.5 Siemens Healthcare Recent Developments/Updates
6.7 Becton, Dickinson and Company
6.6.1 Becton, Dickinson and Company Corporation Information
6.6.2 Becton, Dickinson and Company Description and Business Overview
6.6.3 Becton, Dickinson and Company Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Becton, Dickinson and Company Molecular Diagnostics Systems Product Portfolio
6.7.5 Becton, Dickinson and Company Recent Developments/Updates
6.8 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation)
6.8.1 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Corporation Information
6.8.2 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Description and Business Overview
6.8.3 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Molecular Diagnostics Systems Product Portfolio
6.8.5 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Recent Developments/Updates
6.9 Biom茅rieux Sa
6.9.1 Biom茅rieux Sa Corporation Information
6.9.2 Biom茅rieux Sa Description and Business Overview
6.9.3 Biom茅rieux Sa Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Biom茅rieux Sa Molecular Diagnostics Systems Product Portfolio
6.9.5 Biom茅rieux Sa Recent Developments/Updates
6.10 Cepheid Inc
6.10.1 Cepheid Inc Corporation Information
6.10.2 Cepheid Inc Description and Business Overview
6.10.3 Cepheid Inc Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Cepheid Inc Molecular Diagnostics Systems Product Portfolio
6.10.5 Cepheid Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Molecular Diagnostics Systems Industry Chain Analysis
7.2 Molecular Diagnostics Systems Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Molecular Diagnostics Systems Production Mode & Process
7.4 Molecular Diagnostics Systems Sales and Marketing
7.4.1 Molecular Diagnostics Systems Sales Channels
7.4.2 Molecular Diagnostics Systems Distributors
7.5 Molecular Diagnostics Systems Customers
8 Molecular Diagnostics Systems Market Dynamics
8.1 Molecular Diagnostics Systems Industry Trends
8.2 Molecular Diagnostics Systems Market Drivers
8.3 Molecular Diagnostics Systems Market Challenges
8.4 Molecular Diagnostics Systems Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Abbott Laboratories
Qiagen N.V.
Roche Diagnostics
Hologic, Inc.
Grifols
Siemens Healthcare
Becton, Dickinson and Company
Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation)
Biom茅rieux Sa
Cepheid Inc

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂